|
|
|
|||||
Archive:
| |||||
The increased operating expenses for fiscal year 2007 were primarily the result of an increase in Phase 3 registration clinical trial expenses for clevudine for the treatment of chronic hepatitis B virus (HBV) infection, as well as drug discovery, non-cash stock compensation and depreciation expenses ... Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). (PR Newswire)
Nonhospital health-care workers at substantial risk of exposure to bloodborne pathogens Dec 21, 2007
Findings from the study also suggest that many of the exposed nurses may be at increased risk of infection with serious bloodborne pathogens, such as the human immunodeficiency virus (HIV), hepatitis C virus and hepatitis B virus, since only 65% of these serious exposures were ever formally reported to the nurses administrator. Fear of getting into trouble, not having enough time to report, and not knowing how to report an exposure, were the three most common reasons given for not reporting. (EurekAlert!)
Standard Hepatitis B Treatment Bested by Newcomer Dec 20, 2007
This occurs in only about 6 percent of people over 5 who are infected with the hepatitis B virus, in about 30 percent of infected children between 1 and 5 years old, and in as many as 90 percent of babies who are infected with the virus ... The goal of treatment is to keep levels of the hepatitis B virus as low as possible ... The number of study volunteers who had undetectable levels of hepatitis B virus by the end of the treatment year were much greater for those on telbivudine. (Health-Finder)
Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B Dec 20, 2007
Background Reducing hepatitis B virus (HBV) replication to minimal levels is emerging as a key therapeutic goal for chronic hepatitis B.. Methods In this double-blind, phase 3 trial, 1370 patients with chronic hepatitis B were randomly assigned to receive 600 mg of telbivudine or 100 mg of lamivudine once daily. (New England Journal of Medicine)
Hepatitis B Vaccine Not Associated With Childhood Multiple Sclerosis Dec 5, 2007
4, 2007) Vaccinating against the hepatitis B virus does not appear to be associated with the risk of developing multiple sclerosis in childhood, according to a new article ... (May 1, 2007) Bananas have emerged as the best candidate to deliver a bite-sized vaccine for hepatitis B virus (HBV) to millions of people in developing countries, according to a recent. (Science Daily)
Hepatitis B Vaccine Is Not Linked To Multiple Sclerosis In Childhood Dec 5, 2007
This controversy created public misgivings about hepatitis B vaccination. Hepatitis B vaccination in children remained low in several countries despite vaccination campaigns supporting early vaccination against hepatitis B in children as a means of inducing strong and long-lasting immunity and despite high levels of hepatitis B-related morbidity and mortality worldwide. (Medical News Today)
Pill Boosts Platelets In Hepatitis C Patients Nov 30, 2007
Scientists have investigated 67 spontaneously recovered patients and found that co-infection by hepatitis B virus is. (May 14, 2007) Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. (Science Daily)
Migration 'fuelling rise in Hepatitis B' Nov 22, 2007
The Foundation's report said: "Much more needs to be done. "There is a serious risk that in the future, while chronic hepatitis B virus (HBV) infection declines in countries which have implemented universal vaccination, the UK - that great pioneer of public health - will continue to harbour an ever-increasing pool of chronic HBV infection. " The Hepatitis B Foundation UK now estimates that there are some 326,000 cases, compared to 180,000 in 2002. However, it acknowledges these figures are of... (Daily Mail)
Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania Nov 22, 2007
With increased availability of antibiotics and antifungal agents hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are becoming a cause for significant concern in HIV infected children. We determined the seroprevalence and risk factors for HBV and HCV among HIV infected children aged 18 months to 17 years, attending the Paediatric HIV Care and Treatment Center (CTC) at Muhimbili National Hospital (MNH) in Dar-es-Salaam, Tanzania. (BioMed Central)
GNI Announces IND Approval in China for Novel Liver Disease Drug F351 Nov 21, 2007
The principal causes of liver fibrosis/cirrhosis in Japan and China are viral infection by the Hepatitis B virus or Hepatitis C virus. Alcohol abuse and fatty liver may also lead to liver fibrosis. (BusinessWire)
Migration 'fuelling Hepatitis B' Nov 21, 2007
The Hepatitis B virus is transmitted through contact with the bodily fluids of an infected person, for instance via unprotected sex or the sharing of contaminated needles. We are not in the middle of a major public health problem yet, but we need to start looking ahead before we find ourselves in one. (BBC News -- Health)
New wave of immigration blamed for doubling of hepatitis B cases Nov 21, 2007
There is a serious risk that in the future, while chronic hepatitis B virus (HBV) infection declines in countries which have implemented universal vaccination, the UK that great pioneer of public health will continue to harbour an ever-increas-ing pool of chronic HBV infection. Damian Green, the Conservative immigration spokesman, said: This is an alarming report and it is reasonable to expect from the Government an urgent response about testing those people coming into the country. (Times Online)
Most Brits Susceptible To Hepatitis B Infection - UK One Of Few ... Nov 12, 2007
180,000 people in the United Kingdom are chronically infected with the hepatitis B virus - about 7,700 new infections occur annually ... This would generate a group of immune people more quickly than universal infant immunization alone and accelerate the control of the hepatitis B virus in the UK.. (Medical News Today)
Hepatocellular Carcinoma in Men Nov 8, 2007
The large majority of cases occur in patients with chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). The relative risk of hepatocellular carcinoma in patients with chronic HBV or HCV infection is about 25 to 30 times that of those without infection. (New England Journal of Medicine)
Protect yourself, get the flu shot Nov 7, 2007
Each vaccine contains three influenza viruses one A (H3N2) virus, one A (H1N1) virus, and one B virus. The viruses in the vaccine change each year based on international surveillance and scientists' estimations about which types and strains of viruses will circulate in a given year. (Greenville Delta Democrat Times, MS)
Springfield eyed as home of monkey that bit two kids in Columbia Nov 4, 2007
The monkey was identified through photographs as a rhesus macaque, a species known in rare instances to carry Simian B virus, a deadly disease. Worley identified the animal's possible owner as Libby Brozovich, of Springfield. (Jefferson City News Tribune, MO)
Gilead Issues More Viread Data Nov 3, 2007
Gilead Sciences ( - - ) on Friday issued positive 48-week data from two late-stage trials on the safety and efficacy of Viread among patients with hepatitis B virus (HBV). The Foster City, Calif. (TheStreet.com)
Merck licenses rights to new hepatitis B vaccine Nov 2, 2007
Heplisav consists of a portion of the hepatitis B virus linked to a short DNA sequence aimed at bolstering immune response. The DNA sequence does that by stimulating a toll-like receptor, one of a family of sentries that activate the immune system's early response to infection. (International Herald Tribune -- Business)
Valley researchers pursue cancer vaccine Oct 28, 2007
Similarly, the hepatitis B vaccine, which prevents infection with the hepatitis B virus, prevents some forms of liver cancer. How do therapeutic cancer vaccines differ from the proposed preventive one. (AZCentral)
Discovery Of New Antiviral Mechanism Promising For Hepatitis C Treatment Oct 23, 2007 Kids with Chronic Hepatitis B Generally Do Well Oct 19, 2007 Malaria Vaccine Trial On Babies Shows Promising Results Oct 19, 2007 Structure of influenza B virus protein gives clues to next pandemic Oct 16, 2007 New Test Makes Bird Flu Detection Easier, Cheaper Sep 27, 2007 Liver Cancer Marker Could Yield Blood Test For Early Detection Sep 21, 2007 Blood Marker Might Help Spot Early Liver Cancer Sep 19, 2007 HCV And HBV Spreading More Slowly Among Injection Drug Users In San Francisco Sep 11, 2007 Breast Cancer -leading cause of death in African women Sep 7, 2007 Who Will Recover Spontaneously From Hepatitis C Virus Infection? Sep 6, 2007 Tibotec Pharmaceuticals Ltd Returns MIV-210 Licensing Rights to Medivir Sep 4, 2007 Medivir: New Partner for MIV-210 Sep 4, 2007 Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial Aug 27, 2007 New Test Improves Detection Of Liver Cancer Aug 10, 2007 Father to Child Hepatitis B Transmission Reported Jul 27, 2007 Korean Mummies May Provide Clues To Combat Hepatitis B Jul 27, 2007 Hepatitis B found in South Korean mummy's liver Jul 27, 2007 Korean child mummy holds clues to disease Jul 26, 2007 Korean Mummies Reveal Medical Clues, Love Poems Jul 26, 2007 viral hepatitis Jul 23, 2007 Protecting HIV Patients From Hepatitis B Virus Jul 19, 2007 University of Colorado licenses two influenza virus detection discoveries to Quidel Corp. Jul 19, 2007 Researchers find distinctive patterns of cancer in Asian-Americans Jul 11, 2007 7/5: Tupofse.B Virus Infects Microsoft Word and Excel Files Jul 7, 2007 Stanford free clinic launches Hepatitis B campaign Jul 6, 2007 14% of Vietnamese population suffer from hepatitis B Jul 2, 2007 Hepatitis B Drug Can Compromise HIV Treatment Jun 22, 2007 Entecavir Inhibition of HIV-1 Replication Jun 21, 2007 Remicade data in ankylosing spondylitis show improvement in spinal mobility and spinal inflammation Jun 15, 2007 Puerto Rico Farms Overrun by Monkeys Jun 14, 2007 Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes Jun 2, 2007 The Total Value of the South Korean Pharmaceuticals Market is Expected to Reach US$21.2bn by 2011 May 28, 2007 Hepatitis B patients' understanding of infection and treatment deficient May 26, 2007 Highly Sensitive and Accurate Roche HIV-1 Test Approved by FDA May 12, 2007 Abbott's HIV-1 Viral Load Test Approved by FDA for Use on New m2000(TM) Molecular Diagnostics Instrument May 12, 2007 Experts to train immune cells to kill nose cancer May 9, 2007 Anadys Presents Results From Its NS5b HCV Program at International Conference on Antiviral Research May 3, 2007 Woman contracts hep B during oral surgery May 3, 2007 WHO Collaborating Centre for Patient Safety Releases Nine Life-Saving Patient Safety Solutions May 2, 2007 Toward A Banana-based Vaccine For Hepatitis B May 2, 2007 Summary for Patients May 1, 2007 Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients Apr 30, 2007 Pharmasset Prices Initial Public Offering Apr 27, 2007 Analysis: Access is next HPV front Apr 21, 2007 FDA approves first H5N1 vaccine for human use Apr 18, 2007 FDA CAPSULES Apr 17, 2007 Four-Year Data Demonstrate Continued Low Incidence of BARACLUDE(R) (entecavir) Resistance in Nucleoside-naive Chronic Hepatitis B Patients Apr 15, 2007 Some Drug Resistance To Influenza B Medications Apr 10, 2007 FDA Approves Cangene's Hepagam B For A Second Indication Apr 10, 2007 Cangene reports FDA approval of HepaGam hepatitis B treatment Apr 9, 2007 FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients Apr 7, 2007 Flu Showing Signs Of Resistance To Antivirals Apr 7, 2007 Viral Hepatitis in HIV Infection Apr 5, 2007 Study finds drug-resistant flu virus in Japan Apr 4, 2007 Rare case of dental patient-to-patient hepatitis B virus transmission recorded Apr 4, 2007 Influenza B viruses become resistant to Tamiflu Apr 4, 2007 FDA approves accelerated dosing schedule for Glaxosmithkline's Twinrix Apr 3, 2007 Antibodies and Autoantibodies Mar 25, 2007 Canadian awarded $1.8-million prize Mar 15, 2007 Sportsmen Beware of Hepatitis B Mar 4, 2007 Hepatitis B found in sweat of Olympic athletes Mar 4, 2007 Sweat May Spread Hepatitis B Virus Mar 3, 2007 Sweat May Pass On Hepatitis B In Contact Sports Mar 3, 2007 Rugby players should have hepatitis jab, say scientists Mar 1, 2007 Ghanaians advised to test for Hepatitis B Feb 28, 2007
Scientists have investigated 67 spontaneously recovered patients and found that co-infection by hepatitis B virus is. (Sep. (Science Daily)
Successful Malaria Vaccine Also Proves Effective in Infants Oct 20, 2007
RTS,S works by fusing a protein secreted by the malaria parasite with a molecule on the surface of hepatitis B virus that the human immune system recognizes and attacks. The researchers speculate that it works much like other vaccines, especially because the amount of protection conferred depends on the amount of malaria antibodies in the blood and malaria-recognizing, disease-fighting T cells in the liver. (Scientific American)
There was no evidence that interferon therapy helped the patients rid themselves of hepatitis B virus in the long-term. "These findings should be considered when selecting candidates for treatment and choosing antiviral agents," the investigators suggest. (MEDLINEplus)
The vaccine comprises a protein from the malaria parasite fused onto the surface of hepatitis B virus which the immune system recognizes and attacks. The vaccine was made by GlaxoSmithKline in partnership with the Path Malaria Vaccine Initiative and the trial was funded by the Bill and Melinda Gates Foundation. (Medical News Today)
Qinghua Wang, assistant professor of biochemistry and molecular biology at BCM, and Jianpeng Ma, associate professor in the same department and their colleagues describe the actual structure of influenza B virus hemagglutinin and compare it to a similar protein on influenza A virus ... What would it take for the bird flu to mutate and start killing people" Thats the next part of our work, said Ma. Understanding that change may give scientists a handle on how to stymie it. There are two main... (EurekAlert!)
The researchers also point out that the system could be easily adapted to test for other disease-causing viruses such as HIV, SARS or hepatitis B virus. SOURCE: Nature Medicine, online September 23, 2007. (MEDLINEplus)
Due to widespread hepatitis B virus (HBV) infection, nearly 10 percent of China's population is at high risk for hepatocellular carcinoma (HCC), a liver cancer with low survival rates if not detected and treated early. Researchers report on a new blood screening technique that could make it possible to detect early-stage liver cancer and predict how well a patient will do following treatment. (Science Daily)
They found an altered version of RASSF1A -- a tumor suppressing gene -- in the blood of patients with hepatocellular carcinoma (HCC) and in 58 percent of patients infected with hepatitis B virus (HBV), which increases the risk of liver cancer. The altered gene was not detected in healthy people. (Health-Finder)
Reference: "Seroprevalence of Hepatitis C Virus and Hepatitis B Virus Among San Francisco Injection Drug Users, 1998-2000." Tseng, Fan-Chen; O'Brien, Thomas; Zhang, Mingdong; Kral, Alex; Ortiz-Conde, Betty; Lorvick, Jennifer; Busch, Michael P.; Edlin, Brian. Hepatology; September 2007; (DOI: 10. (Science Daily)
Dr Wiafe Addai stressed the need for an aggressive approach to breast cancer awareness creation and concerted efforts from stakeholders, corporate bodies, companies and individuals to reduce breast cancer mortality and morbidity by 20 to 50 per cent. She also educated the women on Hepatitis B a disease which she claimed was equally deadly and more infectious than HIV/AIDS. Dr Wiafe Addai explained that it was a liver disease caused by a Hepatitis B virus and transmitted through contact with... (Ghana Web, Ghana)
Another interesting conclusion reached by these investigators is, co-infection by hepatitis B virus (HBV) is associated with a higher possibility of self recovery. The investigators suggested that the infection of HBV interferes with the HCV replication, which would finally lead to virus eradiacation. (Science Daily)
In previously performed pre-clinical trials, MIV-210 has demonstrated very potent activity against Hepatitis B Virus (HBV) and has good pharmacokinetic properties. MIV-210 belongs to the class of polymerase inhibitors being administered by subsidiary Medivir HIV Franchise AB.. (BusinessWire)
MIV-210 is a polymerase inhibitor and belongs to the group of projects which is administered by subsidiary Medivir HIV Franchise AB. Noken intends to develop MIV-210 to a pharmaceutical for the treatment of Hepatitis B Virus (HBV). An estimated 120 million Chinese are chronically infected with HBV and 30 million of these are at risk of the disease escalating to liver cancer and cirrhosis. (BusinessWire)
"Liver cancer incidence continues to rise in the Asia-Pacific region, due to the high prevalence of hepatitis B virus infection," said Dr. Ann-Lii Cheng, principal investigator and professor of medicine, National Taiwan University Hospital ... (4) Risk factors for liver cancer include ongoing (chronic) infection with hepatitis B virus (HBV) and/or hepatitis C virus (HCV). (PR Newswire)
By examining blood concentrations in Chinese patients with cirrhosis of the liver due to a hepatitis B virus infection, they found that the quantities of two particular sugar groups that appear on the blood proteins varied according to the stage of the disease. Furthermore, these values correlated with the size of the tumor. (Science Daily)
NEW YORK (Reuters Health) - Molecular evidence indicates that father-to-child transmission is an "important route" of hepatitis B virus (HBV) infection in Japan, Japanese researchers warn in the Journal of Medical Virology. "At present, only high-risk infants born to chronic HBV-infected mothers are given HBV vaccine," note Dr. Hitoshi Tajiri, of Osaka General Medical Center, and colleagues. (MEDLINEplus)
The South Korean mummies are particularly well preserved, and could provide crucial information in the evolution of the hepatitis B virus. An international killer. (Science Daily)
BEIJING, July 26 (Xinhuanet) -- The liver of a 500-year-old child mummy unearthed in South Korea still holds samples of the hepatitis B virus, which will aid scientists to understand how the virus evolved to its present state and what to expect in the future. This is the first time hepatitis B has been found in a mummified body. (Xinhuanet, China)
Its liver still contains hepatitis B virus, helping scientists learn about it ... The liver of a child mummy preserved for 500 years still holds samples of the hepatitis B virus. (MSNBC -- Environment)
One of the exquisitely preserved bodies still contains traces of the hepatitis B virus, which scientists hope will provide clues to treating the modern version of the deadly liver disease. RELATED. (National Geographic)
By 1975 laboratory tests to identify HAV and hepatitis B virus (HBV) infection became available, but by the 1980s it was clear that most cases of post-transfusion hepatitis were caused neither by HAV nor HBV. Originally referred to as non-A, non-B hepatitis, it is mainly caused by hepatitis C virus (HCV). Using chimpanzees as an animal model, it was found in 1983 that the presumptive agent contained a lipid envelope, and it was only after the application of molecular cloning techniques to the... (Suite101.com)
Since the transmission of HIV and Hepatitis B virus (HBV) are so similar, individuals infected with one of these viruses are at a significantly increased risk for contracting the other. As it is not quite clear how patients that don't respond to the HBV vaccine should be managed, new research from the University of Alberta has evaluated the immune response of HBV vaccine given intradermally (into the skin) in HIV-infected individuals who failed to respond to two cycles of HBV vaccine given... (Science Daily)
The BChip can detect two influenza B virus strains (B/Victoria/2/87 and B/Yamagata/16/88), which are critical in determining seasonal influenza vaccines. In a recent study of 62 influenza B virus samples from 19 countries, dating from 1945 to 2005, as well as five negative control samples, the BChip exhibited 97% sensitivity and 100% specificity, with no false positives. (EurekAlert! -- Business News)
The hepatitis B virus is endemic in Asia, McCracken said, and chronic infection is a major cause of liver cancer there and in recent immigrants. A study last year found high rates of infection in East Asian immigrants in New York. (International Herald Tribune -- Health)
B Virus Infects Microsoft Word and Excel Files ... B Virus Infects Microsoft Word and Excel Files July 5, 2007 W32. (CIO Information Network)
For those already chronically infected with the hepatitis B virus, the clinic will provide appropriate monitoring with blood tests and liver ultrasounds, referrals and antiviral treatment. Related Industry stories. (San Jose Business Journal, CA)
In much of the developing world, most people become infected with the hepatitis B virus (HBV) during childhood, and 8-10 percent of people in the general population become chronically infected. HBV is transmitted by contact with blood or body fluids of an infected person in the same way as HIV, the virus that causes AIDS. However, HBV is 50 to 100 times more infectious than HIV, said the organization. (Xinhuanet, China)
The drug blocks viral replication by plugging itself into a polymerase enzyme in the hepatitis B virus that helps produce new viral DNA. However, the hepatitis B polymerase closely resembles the reverse transcriptase enzyme that HIV uses to copy its genome inside an infected cell. Thus, there was a possibility that treating co-infected patients for hepatitis B with entecavir might also have an effect on HIV. But earlier tests by Bristol-Myers Squibb using techniques available at the time did not... (Science Daily)
Entecavir, a drug approved by the Food and Drug Administration for the treatment of chronic hepatitis B virus (HBV) infection, is not believed to inhibit replication of human immunodeficiency virus type 1 (HIV-1) at clinically relevant doses. We observed that entecavir led to a consistent 1-log10 decrease in HIV-1 RNA in three persons with HIV-1 and HBV coinfection, and we obtained supportive in vitro evidence that entecavir is a potent partial inhibitor of HIV-1 replication. (New England Journal of Medicine)
Reactivation of hepatitis B virus has been reported in patients who are carriers of this virus and are taking TNF blockers, such as REMICADE. Some of these cases have been fatal. Tell your doctor if you know or think you may be a carrier of hepatitis B virus or if you experience signs of hepatitis B infection, such as feeling unwell, poor appetite, tiredness, fever, skin rash and/or joint pain. (EurekAlert!)
Ferrer also said the animals threaten bird populations by eating eggs, and some carry the Herpes B virus, which can be fatal to humans. Fears that they could transmit the disease intensified after a farmer bitten two years ago in Lajas died of unknown causes, he said. (Fox News)
Public release date: 1-Jun-2007. They are more likely to develop severe hepatitis during chemotherapy. (EurekAlert!)
Domestic firm Bukwang Pharmaceutical received Korean Food & Drug Administration (KFDA) approval for its hepatitis B virus infection, Levovir (clevudine), in November 2006. Bukwang invested over KRW90bn (US$96mn) in Levovir, which after clinical tests in more than six countries, has been shown to be effective in suppressing the hepatitis B virus in 92% of patients. (BusinessWire)
80 percent were aware of the long-term consequences of the hepatitis B virus ... 31 percent said they knew specific names of hepatitis B virus tests, but only half knew what the tests measured. (EurekAlert!)
The HIV-1 test is the first on this automated platform approved for use in the US. The HCV test for this platform is currently under review by the US FDA. The agency is also currently reviewing the Roche Diagnostics Cobas TaqMan HBV Test, which is designed for use with High Pure sample preparation reagents and the Cobas TaqMan 48 analyzer for automated amplification and detection of Hepatitis B virus in human blood. About Roche and the Roche Diagnostics Division Headquartered in Basel,... (PR Newswire)
Additional products in development for the Abbott m2000 system include assays for hepatitis C virus (HCV), hepatitis B virus (HBV), HCV genotyping, chlamydia and gonorrhea. Abbott markets the m2000 system and a menu of tests throughout the world as part of a strategic alliance with Celera. (PR Newswire)
If the technique works, it could be tried on other cancers with well-established links to viruses, for example, liver cancer, which is linked to hepatitis B virus, Chua said. Copyright 2007 Reuters. (The Star Online, Malaysia)
Most patients suffering from liver cancer who do not have hepatitis B virus infection have evidence of HCV infection. The mechanisms by which HCV infection leads to liver cancer are still unclear. (PR Newswire)
NEW YORK - Hepatitis B virus was transmitted from one patient to another when they both underwent oral surgery in the same office on the same day despite proper infection control measures public health officials report ... A cross-match of the state department of healths hepatitis B registry found a patient infected with hepatitis B virus who had oral surgery a couple hours earlier that day ... Hepatitis B virus can persist in dried blood on surfaces for a week or longer, and can also... (MSNBC -- Health)
-- Single Use of Injection Devices -- One of the biggest global concerns is the spread of Human Immunodeficiency Virus (HIV), the Hepatitis B Virus (HBV), and the Hepatitis C Virus (HCV) because of the reuse of injection needles. The recommendations address the need for prohibitions on the reuse of needles at health care facilities; periodic training of practitioners and other health care workers regarding infection control principles; education of patients and families regarding transmission of... (PR Newswire)
Bananas have emerged as the best candidate to deliver a bite-sized vaccine for hepatitis B virus (HBV) to millions of people in developing countries, according to an article scheduled for the June 1 issue of ACS' Biotechnology Progress, a bi-monthly journal co-published with the American Institute of Chemical Engineers. In the article, India's V. A. Bapat and colleagues update and review worldwide research on efforts to genetically engineer plants as biofactories for the production of vaccines. (Science Daily)
Does Exposure to Hepatitis B Virus Increase the Risk for Liver Cancer in Patients with Hepatitis C Infection ... Two of the viruses, hepatitis B virus (HBV) and hepatitis C virus (HCV), can cause chronic infection that may progressively damage the liver ... Summaries for PatientsDoes Exposure to Hepatitis B Virus Increase the Risk for Liver Cancer in Patients with Hepatitis C Infection. (Annals of Internal Medicine)
Every year in Europe an estimated one million people are infected with the hepatitis B virus and 90,000 will become chronic carriers and 24,000 will die(1) CAMBRIDGE, Mass ... "There is no cure for chronic hepatitis B. High hepatitis B viral load increases the risk of serious complications. To reduce this risk, the goal of therapy is to suppress the hepatitis B virus as much as possible, and to maintain that decrease over time." Worldwide regulatory submissions have been based primarily on... (PR Newswire)
Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Contact: Alan S. Roemer Office: (609) 613-4125. (PR Newswire)
He did note, however, that most states mandate vaccination against hepatitis B virus, also a sexually transmitted pathogen. At the AACR meeting, Gall reported on results of treatment of more than 1,100 women who received Cervarix. (United Press International)
No, current annual influenza vaccines include three influenza viruses, A subtypes H3N2 and H1N1 viruses, and one B virus. A vaccine made from these viruses would not provide protection against a different influenza A subtype virus (such as H5N1). (Food Consumer)
Liver transplant patients who have already been exposed to the hepatitis B virus are at an increased risk of reinfection. HepaGam B works by providing an immediate immune response to the virus. (Newsday -- Health)
About BARACLUDE(R) (entecavir) Discovered at Bristol-Myers Squibb, BARACLUDE(R) (entecavir) is a nucleoside analogue indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication with either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease ... 5mg/1mg Tablets BARACLUDE(R) (entecavir) is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults where... (PR Newswire)
There has been documented evidence of the emergence of oseltamivir-resistant type A viruses, but similar information on influenza B viruses has been limited. Influenza B viruses are associated with annual outbreaks of illness and increased death rates worldwide, according to background information in the article ... D., of the University of Tokyo, Japan, and colleagues examined the prevalence and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors in... (Science Daily)
HepaGam B is Cangene's Hepatitis B Immune Globulin Intravenous (Human), which is a purified antibody or hyperimmune that is specific for the hepatitis B virus ... HepaGam B was approved last year by the FDA for treatment following acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute hepatitis B virus infection, and was approved earlier this year by Health... (Playfuls.com)
HepaGam B received FDA approval last year for treatment following acute exposure to blood containing the hepatitis B surface antigen, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and for household exposure to persons with acute hepatitis B virus infection. It received Health Canada approval this year for prevention of hepatitis B recurrence following liver transplantation. (Globe and Mail -- Business)
HepaGam B(TM) is Cangene's Hepatitis B Immune Globulin Intravenous (Human), which is a purified antibody or hyperimmune that is specific for the hepatitis B virus ... HepaGam B(TM) was approved last year by the FDA for treatment following acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute hepatitis B virus infection, and was approved earlier this year by... (PR Newswire)
And another commentary in Journal Watch, another JAMA publication, suggests that while this study shows a low level of resistance in the Influenza B virus compared with Influenza A (5-18 per cent) and only speculates about transmissibility, the findings "are worrisome and deserve follow-up" ... "Emergence of Influenza B Viruses With Reduced Sensitivity to Neuraminidase Inhibitors." Shuji Hatakeyama; Norio Sugaya; Mutsumi Ito; Masahiko Yamazaki; Masataka Ichikawa; Kazuhiro Kimura; Maki Kiso;... (Medical News Today)
Please for full text and personal services. Volume 356:1445-1454. (New England Journal of Medicine)
The study involved an influenza B virus outbreak in the winter of 2004-2005 that caused a widespread epidemic. Writing in this week's journal of the American Medical Association, researchers said they collected flu B virus samples from 74 children before and after Tamiflu use and from 348 influenza patients -- also mostly children -- who were not treated with the drug ... In addition, seven of the 422 influenza B viruses isolated from untreated patients were found to have reduced sensitivity to... (Scientific American)
Researchers have documented a case of hepatitis B virus (HBV) transmission between two patients at a dentist's office in the United States ... This is the only known documented case of hepatitis B virus transmission between two dental patients in the United States. (EurekAlert!)
But rare evidence has been reported to suggest that influenza B viruses have been mutated to resist these drugs ... D., of the University of Tokyo, Japan, and colleagues examined the prevalence and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors in Japan where both Tamiflu and Relenza are used more extensively than anywhere else in the world ... The researchers collected influenza B isolates from 74 children before and after Tamiflu therapy and from... (Food Consumer)
Hepatitis B is a serious liver disease caused by the hepatitis B virus. The virus is passed through infected blood or body fluids. (EurekAlert! -- Business News)
For instance hepatitis B immune globulin or HBIG is a passive vaccine that contains antibodies to the hepatitis B virus. HBIG is given immediately after unvaccinated individuals, for instance newborns during childbirth, are exposed to hepatitis B. Passive antibodies last about 3 months. (Suite101.com)
" The prize-giver: Sir John Marks Templeton, 94, above, American-born British stock investor, international money manager and philanthropist who established the Templeton Foundation to fund research into life's Big Questions such as (according to its website): Do we have a soul? Is mathematics discovered or invented? Do we have free will? Is the universe infinite? What is creativity? What is time? The judges: Nine international academics and theologians including Nobel laureate Baruch Blumberg,... (Globe and Mail -- International)
Researchers studied the blood samples from 70 Olympic wrestlers of ages between 18 and 30 and tested them for hepatitis B virus ... Selda Bereket-Ycel at the Celal Bayar University in Turkey said, 'The results of this study suggest that sweating may be another way of transmitting hepatitis B virus,' she said ... The researchers conclude: 'Clinicians and staff of athletic programmes should aggressively promote hepatitis B virus immunization. (MedIndia)
The Hepatitis B virus attacks the liver and causes a lifelong infection in approximately 5% of adults who catch it. It can cause cirrhosis (scarring) of the liver, liver cancer, liver failure, and can be fatal. (News-Medical.net)
NEW YORK (Reuters Health) - Findings from a study of Olympic wrestlers indicate that hepatitis B virus is found in the sweat of infected individuals, and so sweating might be a way that the virus could be passed between participants in contact sports ... Dr. S. Bereket-Yucel, from Celal Bayar University in Izmir, Turkey, tested for DNA of the hepatitis B virus in blood and sweat samples from 70 male Olympic wrestlers ... The results indicated that 9 (13 percent) of the wrestlers had the... (MEDLINEplus)
Hepatitis B virus attacks the liver and can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. The research team analysed blood and sweat samples from 70 male Olympic wrestlers for evidence of hepatitis B infection (HBV). (Science Daily)
In the study researchers took blood samples from 70 Olympic wrestlers aged between 18 and 30 and tested them for traces of the hepatitis B virus ... "The results of this study suggest that sweating may be another way of transmitting hepatitis B virus," she said ... The researchers conclude: "Clinicians and staff of athletic programmes should aggressively promote hepatitis B virus immunisation. The advice of sports organisations should be changed, making hepatitis B virus immunisation obligatory... (Guardian Unlimited)
She said Hepatitis B was a liver disease caused by Hepatitis B virus and transmitted through contact with infected blood and body fluids. She said once infected, the virus caused chronic infections and later the victims developed liver scarring (cirrhosis) or liver cancer. (Ghana Web, Ghana)
Back to FindHealthNews Home
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.
Copyright SurfWax, Inc. 2006 |